Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06816329 · ClinicalTrials.gov registry record · NA

Stress Dynamics and Familial Risk for Depression in Female Adolescents

A NA study of Major Depressive Disorder, sponsored by Mclean Hospital.

Recruiting
Registry status
NA
Development phase
148
Enrollment target
1
Study location

NCT06816329: Recruiting NA study of Major Depressive Disorder, sponsored by Mclean Hospital.

NCT06816329 is a NA study of Major Depressive Disorder that is actively recruiting participants, run by Mclean Hospital. The registered enrollment target is 148 participants, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06816329, a NA study of Major Depressive Disorder, is actively recruiting participants, sponsored by Mclean Hospital.

RECRUITING
Registry status
NA
Development phase
148 participants
Enrollment target
1
Study location

Study Summary

Stress and a parental history of major depressive disorder (MDD) are among the strongest risk factors for future development of MDD. Studies have shown that having a parental history of MDD may be associated with behavioral, psychophysiological, and hormonal responses to stress that are associated with poorer stress coping. . Adolescence is a vulnerable developmental window linked to increased MDD risk, especially for females, as rates of MDD surge relative to males. Despite the central role of stress in MDD onset, little is known about the brain mechanisms underlying stress responses in susceptible female adolescents at high familial risk for MDD. Also, it is unclear how stress-related brain network alterations may relate to "real-world" maladaptive stress responses and whether these stress-related brain network changes are predictive of future depression onset. We will fulfill these research gaps by combining neuroimaging with intensive longitudinal tracking of depressive symptomology as well as behavioral and physiological responses to "real world" stress using smartphone and smartwatch technology. Elucidating these neural mechanisms may aid in the discovery of MDD biomarkers that could identify youth at greatest risk for future MDD development and lead to earlier intervention efforts.

Primary Outcome

Time Spent in Default Mode-Frontoparietal Network Coactivation Pattern (CAP). An fMRI variable. (the number of volumes spent in this CAP).

Conditions Studied

Interventions

  • BEHAVIORAL Computer Task Manipulation

Study Locations (1)

Massachusetts

  • McLean Hospital - Belmont

Trial Details

FieldValue
Enrollment Target 148 participants
Start Date 2025-10-15
Est. Completion 2030-03-31
Phase NA
Mclean Hospital

140 total trials

What NCT06816329 shows while recruiting

NCT06816329 is an interventional study that assigns participants to a tested intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (61% lower).

The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 1 intervention - of which Computer Task Manipulation is the first listed.

NCT06816329 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06816329 about?

NCT06816329 is a clinical study titled "Stress Dynamics and Familial Risk for Depression in Female Adolescents". Stress and a parental history of major depressive disorder (MDD) are among the strongest risk factors for future development of MDD. Studies have shown that having a parental history of MDD may be associated with behavioral, psychophysiological, and hormonal responses to stress that are associated w...

What is the current status of trial NCT06816329?

This trial is currently recruiting. It is a NA study. The enrollment target is 148 participants. The study started on 2025-10-15. Estimated completion is 2030-03-31.

What conditions does trial NCT06816329 study?

This clinical trial studies the following conditions: Major Depressive Disorder.

What interventions are being tested in trial NCT06816329?

The interventions under investigation include: Computer Task Manipulation (BEHAVIORAL).

Who is sponsoring clinical trial NCT06816329?

This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06816329 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06816329's enrollment target sits among peer trials

148 101st of 282 higher than 180 of 282 other Major Depressive Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Major Depressive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00739362 · 148 participants · Phase 2

    Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment

  • NCT03161223 · 148 participants · Phase 1

    Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma

  • NCT03858231 · 148 participants · Phase 4

    Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery

  • NCT04486352 · 148 participants · Phase 1

    A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06816329, the US trial registry maintained by the National Library of Medicine. NCT06816329 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.